Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

Potential clinical implications of HPV status and expressions of p53 and cyclin D1 among oropharyngeal cancer patients.

David Lu XJ, Liu KYP, Soares RC, Thomson T, Prisman E, Wu J, Poh CF.

J Oral Pathol Med. 2018 Sep 6. doi: 10.1111/jop.12779. [Epub ahead of print]

PMID:
30191616
2.

Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications.

Nikitakis NG, Pentenero M, Georgaki M, Poh CF, Peterson DE, Edwards P, Lingen M, Sauk JJ.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Jun;125(6):650-669. doi: 10.1016/j.oooo.2018.03.012. Epub 2018 Apr 4. Review.

PMID:
29709496
3.

Altered Immune-Related Gene Expressions Indicate Oral Cancer Nodal Disease.

Liu KYP, Lu XJD, Zhu Y, Yip S, Poh CF.

J Dent Res. 2018 Jun;97(6):709-716. doi: 10.1177/0022034518758045. Epub 2018 Feb 28.

PMID:
29489424
4.

Using quantitative tissue phenotype to assess the margins of surgical samples from a pan-Canadian surgery study.

Guillaud M, MacAulay CE, Berean KW, Bullock M, Guggisberg K, Klieb H, Puttagunta L, Penner C, Kwan K, Rosin MP, Poh CF.

Head Neck. 2018 Jun;40(6):1263-1270. doi: 10.1002/hed.25106. Epub 2018 Feb 16.

PMID:
29451953
5.

An actionable test using loss of heterozygosity in identifying high-risk oral premalignant lesions.

Liu KYP, Lu XJD, Cheng YL, Klieb H, Ng S, McNeil K, Karsan A, Poh CF.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Dec 18. pii: S2212-4403(17)31208-7. doi: 10.1016/j.oooo.2017.10.019. [Epub ahead of print]

PMID:
29428696
6.

Tumor-associated immune aggregates in oral cancer: Their cellular composition and potential prognostic significance.

de Sousa Lopes MLD, Liu Y, Liu KY, da Silveira √ČJD, Poh CF.

Med Hypotheses. 2017 Oct;108:17-23. doi: 10.1016/j.mehy.2017.07.017. Epub 2017 Jul 16.

PMID:
29055393
7.

Detection of clinically relevant copy number alterations in oral cancer progression using multiplexed droplet digital PCR.

Hughesman CB, Lu XJD, Liu KYP, Zhu Y, Towle RM, Haynes C, Poh CF.

Sci Rep. 2017 Sep 19;7(1):11855. doi: 10.1038/s41598-017-11201-4.

8.

Dual-mode endomicroscopy for detection of epithelial dysplasia in the mouth: a descriptive pilot study.

Bodenschatz N, Poh CF, Lam S, Lane P, Guillaud M, MacAulay CE.

J Biomed Opt. 2017 Aug;22(8):1-10. doi: 10.1117/1.JBO.22.8.086005.

PMID:
28823113
9.

Improving public awareness and outcomes for oral cancer.

Poh CF.

Future Sci OA. 2016 Feb 11;2(1):FSO103. doi: 10.4155/fsoa-2016-0004. eCollection 2016 Mar.

10.

Prospects in the Application of Photodynamic Therapy in Oral Cancer and Premalignant Lesions.

Saini R, Lee NV, Liu KY, Poh CF.

Cancers (Basel). 2016 Sep 2;8(9). pii: E83. doi: 10.3390/cancers8090083. Review.

11.

Nodal Disease Burden for Early-Stage Oral Cancer.

Liu KY, Durham JS, Wu J, Anderson DW, Prisman E, Poh CF.

JAMA Otolaryngol Head Neck Surg. 2016 Nov 1;142(11):1111-1119. doi: 10.1001/jamaoto.2016.2241.

PMID:
27560665
12.

A Robust Protocol for Using Multiplexed Droplet Digital PCR to Quantify Somatic Copy Number Alterations in Clinical Tissue Specimens.

Hughesman CB, Lu XJ, Liu KY, Zhu Y, Poh CF, Haynes C.

PLoS One. 2016 Aug 18;11(8):e0161274. doi: 10.1371/journal.pone.0161274. eCollection 2016.

13.

Cost-Effectiveness Analysis of Using Loss of Heterozygosity to Manage Premalignant Oral Dysplasia in British Columbia, Canada.

Cromwell I, Regier DA, Peacock SJ, Poh CF.

Oncologist. 2016 Sep;21(9):1099-106. doi: 10.1634/theoncologist.2015-0433. Epub 2016 Jul 11.

14.

Fluorescence Visualization-Guided Surgery for Early-Stage Oral Cancer.

Poh CF, Anderson DW, Durham JS, Chen J, Berean KW, MacAulay CE, Rosin MP.

JAMA Otolaryngol Head Neck Surg. 2016 Mar;142(3):209-16. doi: 10.1001/jamaoto.2015.3211.

PMID:
26769431
15.

Recurring DNA copy number gain at chromosome 9p13 plays a role in the activation of multiple candidate oncogenes in progressing oral premalignant lesions.

Towle R, Tsui IF, Zhu Y, MacLellan S, Poh CF, Garnis C.

Cancer Med. 2014 Oct;3(5):1170-84. doi: 10.1002/cam4.307. Epub 2014 Jul 24.

16.

Oral mucosa optical biopsy by a novel handheld fluorescent confocal microscope specifically developed: technologic improvements and future prospects.

Contaldo M, Poh CF, Guillaud M, Lucchese A, Rullo R, Lam S, Serpico R, MacAulay CE, Lane PM.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Dec;116(6):752-8. doi: 10.1016/j.oooo.2013.09.006.

PMID:
24237726
17.

Photodynamic therapy: a review and its prospective role in the management of oral potentially malignant disorders.

Saini R, Poh CF.

Oral Dis. 2013 Jul;19(5):440-51. doi: 10.1111/odi.12003. Review.

PMID:
24079944
18.

Global analysis of DNA methylation changes during progression of oral cancer.

Towle R, Truong D, Hogg K, Robinson WP, Poh CF, Garnis C.

Oral Oncol. 2013 Nov;49(11):1033-42. doi: 10.1016/j.oraloncology.2013.08.005. Epub 2013 Sep 13.

PMID:
24035722
19.

Cyclin D1 overexpression is associated with poor prognosis in oropharyngeal cancer.

Lin RJ, Lubpairee T, Liu KY, Anderson DW, Durham S, Poh CF.

J Otolaryngol Head Neck Surg. 2013 Mar 19;42:23. doi: 10.1186/1916-0216-42-23.

20.

Ex vivo confocal imaging with contrast agents for the detection of oral potentially malignant lesions.

El Hallani S, Poh CF, Macaulay CE, Follen M, Guillaud M, Lane P.

Oral Oncol. 2013 Jun;49(6):582-90. doi: 10.1016/j.oraloncology.2013.01.009. Epub 2013 Feb 12.

Supplemental Content

Loading ...
Support Center